Stereoselective 6-beta-hydroxy Morphinan Preparation via Crown Ether Mediation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for converting 6-keto morphinan to 6-beta-hydroxy morphinan suffer from low yields and contamination with unconverted starting material due to caustic waste generation and precipitation issues, necessitating an efficient and scalable process for high yield and epimeric purity.

Innovation Solution

A two-step process involving contacting 6-keto morphinan with a reducing agent and a first proton acceptor to form a heterogeneous reaction mixture, followed by addition of a second proton acceptor to convert remaining 6-keto morphinan to 6-beta-hydroxy morphinan, ensuring high yield and purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If the reaction is run in a large volume of alkaline solution, then the reaction proceeds smoothly, but the yields are low and large volumes of caustic waste material are generated

Engineering Contradiction:
Improvereaction smoothnessVSAvoidreaction yield
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The invention changes the concentration parameter of the reaction environment by using a concentrated reaction mixture instead of a large volume dilute solution. This allows the reaction to proceed smoothly while achieving high yields and minimizing waste generation.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If the reaction is run in a concentrated environment, then waste material is minimized, but one of the components precipitates out of solution and the reaction stalls prior to completion

Engineering Contradiction:
Improvewaste minimizationVSAvoidreaction completion
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention adds a crown ether component preliminarily to the concentrated reaction mixture before the precipitation problem occurs. The crown ether complexes with cations to maintain solubility of reaction components, preventing premature precipitation and ensuring the reaction proceeds to completion while maintaining concentrated conditions.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If the reaction is run in a concentrated environment, then caustic waste is reduced, but the resulting product is contaminated with large amounts of unconverted starting material

Engineering Contradiction:
Improvewaste reductionVSAvoidproduct purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The crown ether is added preliminarily to prevent precipitation and ensure complete conversion of starting material to product, thereby achieving both waste reduction and high product purity simultaneously.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The crown ether acts as an intermediary substance that facilitates the reaction by complexing with cations, preventing precipitation, and ensuring complete conversion. This mediator enables the reaction to proceed in concentrated conditions without the harmful effects of component precipitation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process achieves high yields and stereoselective conversion of 6-keto morphinan to 6-beta-hydroxy morphinan with minimal impurities, addressing the limitations of existing methods by maintaining a homogeneous reaction environment and optimizing product isolation.

Implementation Method 1

The stereoselective reduction of the 6-keto group of certain morphinan compounds is a necessary step in the preparation of many opiate-based compounds

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 2

contacting compound (I) with a reducing agent and a first proton acceptor to form a first homogeneous reaction mixture

Methodology Applied
Scientific EffectProton acceptance: Absorption (physical)

Data Source

PatentUS8168790B2Process for the preparation of 6-beta hydroxy morphinan compounds
Publication Date: 2012.05.01 SPECGX LLC
  • US8168790B2 patent drawing
  • US8168790B2 patent drawing
  • US8168790B2 patent drawing

AI summary

The invention provides processes for the conversion of a 6-keto morphinan to a 6-hydroxy morphinan. In particular, the invention provides a stereoselective process for the conversion of a 6-keto morphinan to a 6-beta-hydroxy morphinan.